HIGH SENSITIVE CRP
The High Sensitive C-Reactive Protein (hs-CRP) Test is a blood test that measures very low levels of C-reactive protein, a substance produced by the liver in response to inflammation. Unlike the standard CRP test, the high-sensitivity version is used to evaluate subtle inflammation associated with cardiovascular diseases.
This test is particularly useful in assessing the risk of heart disease, stroke, and other cardiovascular conditions.
The purpose of this test is to:
The High-Sensitive CRP (hs-CRP) test measures very small amounts of C-reactive protein (CRP) in the blood. CRP is produced by the liver in response to inflammation. Because hs-CRP can detect lower levels of CRP than a standard CRP test, it may be useful for assessing low-grade inflammation and cardiovascular risk.
The test may be considered as part of an overall heart disease risk assessment, particularly in people whose cardiovascular risk is uncertain after considering factors such as cholesterol levels, blood pressure, diabetes, smoking, and family history.
An elevated hs-CRP does not specifically identify the cause of inflammation and does not by itself diagnose heart disease. Infection, injury, inflammatory conditions, and other factors can temporarily increase CRP levels. Therefore, the result should be interpreted together with the person's overall clinical picture.
1. What does the High-Sensitive CRP test measure?
The hs-CRP test measures very low levels of C-reactive protein, helping detect low-grade inflammation that may be associated with cardiovascular risk.
2. Is a high hs-CRP level a sign of heart disease?
Not necessarily. An elevated hs-CRP may indicate inflammation but does not diagnose heart disease on its own. Infection, injury, obesity, and other inflammatory conditions can also increase CRP levels.
3. What is the difference between CRP and hs-CRP?
Both tests measure C-reactive protein, but hs-CRP is more sensitive at detecting low CRP concentrations. Standard CRP testing is more commonly used to evaluate significant or acute inflammation, while hs-CRP may be used in selected situations for cardiovascular risk assessment.